Zoe Van De Voorde

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel”.

Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel

Gastrointestinal Endoscopy(2020)10.1016/j.gie.2020.01.037

N/A

0DataRank · unranked

33 citations

Reginald Bell, Barham K. Abu Dayyeh, P.F. Buckley, Kenneth J. Chang, Christy M. Dunst +15 more

Results from the safety lead-in for a phase II study of pembrolizumab in combination with binimetinib and bevacizumab in patients with refractory metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4031

N/A

0DataRank · unranked

8 citations

S. Lindsey Davis, Stephen Leong, Alexis D. Leal, Patrick J. Blatchford, Gurprataap Singh Sandhu +15 more

A phase II study of pembrolizumab, binimetinib, and bevacizumab in patients with microsatellite-stable, refractory, metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.118

N/A

0DataRank · unranked

8 citations

Patrick J. Blatchford, Robert W. Lentz, S. Lindsey Davis, Sunnie S. Kim, Alexis D. Leal +9 more